Infection-related hemolytic uremic syndrome

Hemolytic anemia manifests as fatigue, pallor, and shortness of breath due to the destruction of red blood cells. The biological mechanism involves the premature destruction of red blood cells, often triggered by an immune response or infection. Over time, this can lead to severe anemia and require blood transfusions. It affects daily life by causing fatigue and weakness, and management includes treating the underlying cause and supportive care such as transfusions.

Acute renal failure presents with decreased urine output, swelling, and elevated blood pressure due to impaired kidney function. It is caused by the damage to the small blood vessels in the kidneys, leading to reduced filtration capacity. Without intervention, it can progress to chronic kidney disease or necessitate dialysis. Daily life is impacted by fluid retention and fatigue, and treatment involves managing fluid balance and addressing the underlying cause.

Thrombocytopenia is characterized by easy bruising, prolonged bleeding, and petechiae due to a low platelet count. The condition arises from increased platelet destruction or consumption in the microvasculature. If untreated, it can lead to significant bleeding complications. Patients may need to avoid activities that increase bleeding risk, and treatment may include platelet transfusions or medications to increase platelet count.

Hypertension in this context often presents with headaches, dizziness, and visual disturbances. It results from the kidneys' inability to regulate blood pressure due to vascular damage. Over time, uncontrolled hypertension can lead to cardiovascular complications. Management includes antihypertensive medications and lifestyle modifications to reduce blood pressure.

Gastrointestinal symptoms such as abdominal pain, diarrhea, and vomiting are common in infection-related hemolytic uremic syndrome. These symptoms are often due to the initial infectious trigger, such as a gastrointestinal pathogen. They can lead to dehydration and electrolyte imbalances if persistent. Treatment focuses on rehydration and addressing the underlying infection.

Neurological symptoms may include confusion, seizures, or stroke-like symptoms due to microvascular damage in the brain. These occur when small blood clots obstruct blood flow to parts of the brain. If not addressed, they can lead to long-term neurological deficits. Management involves controlling the underlying hemolytic process and supportive neurological care.

Cardiac involvement can manifest as chest pain, arrhythmias, or heart failure due to reduced blood supply to the heart. This occurs when microthrombi affect coronary circulation. Over time, it can lead to permanent cardiac damage if untreated. Management includes addressing the underlying cause and supportive cardiac care.

Pulmonary symptoms such as shortness of breath and pulmonary edema may occur due to fluid overload and hypertension. These symptoms arise when the kidneys fail to excrete excess fluid, leading to its accumulation in the lungs. If not managed, it can progress to respiratory failure. Treatment involves diuretics and supportive respiratory care.

Clinicians look for a history of recent gastrointestinal infection, particularly with symptoms like diarrhea and vomiting. Important history elements include recent exposure to contaminated food or water and any family history of similar conditions. Physical examination may reveal signs of dehydration, pallor, and edema. This step helps to differentiate between typical and atypical forms of hemolytic uremic syndrome and directs further diagnostic testing.

Ultrasound of the kidneys is the primary imaging modality used, showing signs of renal swelling and possible obstruction. Specific abnormalities include enlarged kidneys and increased echogenicity, which support the diagnosis of acute kidney injury. These findings help confirm the diagnosis of hemolytic uremic syndrome by excluding other causes of renal failure. Differential diagnoses such as acute glomerulonephritis or nephrolithiasis are excluded based on imaging results.

Specific tests ordered include complete blood count, renal function tests, and stool cultures for pathogens like E. coli O157:H7. Biomarkers sought include low hemoglobin, elevated creatinine, and the presence of schistocytes on a blood smear. Abnormal results typically show thrombocytopenia, hemolytic anemia, and renal impairment. These results guide the next steps in management, including potential initiation of supportive care and specific therapies.

Genes such as CFH, CFI, and MCP are sequenced to identify mutations associated with atypical hemolytic uremic syndrome. Mutations found are often in complement regulatory proteins, confirming a diagnosis of complement-mediated HUS. Results confirm the diagnosis and help differentiate from infection-related forms, guiding treatment decisions. Genetic testing also informs family counseling regarding recurrence risks and potential need for genetic screening of relatives.